Stay updated with breaking news from Lucy Codrington. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Bloomberg) — Roche Holding AG cut a fifth of its pipeline of experimental drugs in recent quarters as its new chief executive tries to revive growth after a series of research setbacks. Trimmed so far this year were a trio of cancer projects and an experimental psychiatric compound, Roche said on Wednesday as it reported…
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/7V3YTU47LBJMQFSZSA52SM45QE.jpg)
Company entered obesity drug race last year but its experimental pill remains in early-stage tests
With a market capitalization of 4 billion dollars, Zealand Pharma, a Danish biotech founded in 1998 that also operates in the USA, is aiming to enter the highly lucrative anti-obesity drugs market. In... -January 24, 2024 at 10:14 am EST - MarketScreener
(Bloomberg) -- A new cancer medicine developed by AstraZeneca Plc and Daiichi Sankyo Co. seemed to fall short of investors’ expectations in partial results released early after a data leak at a medical conference. Most Read from BloombergBiden Vows Aid for Gaza, Backs Israel Over Hospital BlastHospital Blast Kills Hundreds as Israel, Hamas Trade BlameStocks Drop, Oil Climbs on Renewed Mideast Risks: Markets WrapUPenn Donors Pile Pressure on School as David Magerman Pulls SupportIsrael Latest: Bi
Here are some of the stocks and sectors that are likely to see the biggest impact from the boom in demand for weight-loss drugs. Read on.